GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arqule, Inc. (ARQL) [hlAlert]

Rating:
Buy ARQL
down 67.82 %

Arqule, Inc. (ARQL) rated Buy with price target $7 by Lazard Capital Mkts

Posted on: Wednesday,  Jun 10, 2009  8:25 AM ET by Lazard Capital Mkts

Lazard Capital Mkts rated Buy Arqule, Inc. (NASDAQ: ARQL) on 06/10/2009, when the stock price was $5.47. Since
then, Arqule, Inc. has lost 67.82% as of 01/22/2016's recent price of $1.76.
If you would have followed this Lazard Capital Mkts's recommendation on ARQL, you would have lost 67.82% of your investment in 2417 days.

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Lazard Capital Markets’ goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Lazard Capital Markets’ industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/10/2009 8:25 AM Buy
None
5.47 7.00
as of 12/31/2009
1 Week up  86.92 %
1 Month up  91.08 %
3 Months up  51.10 %
1 YTD up  25.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy